# A Study to Compare the Efficacy and Safety of a Combination of Ketoconazole and Clindamycin Compared to Tetracycline/Amphotericin B Combination Cream for the Treatment of Bacterial Vaginosis and Vaginal Candidiasis (P08077)

> **NCT01293643** · PHASE3 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 99 (actual)

## Conditions studied

- Vaginosis, Bacterial
- Candidiasis, Vulvovaginal

## Interventions

- **DRUG:** 100 mg clindamycin /800 mg ketoconazole vaginal ovule
- **DRUG:** 100 mg tetracycline hydrochloride /50 mg amphotericin B cream

## Key facts

- **NCT ID:** NCT01293643
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 99 (ACTUAL)
- **Last updated:** 2015-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01293643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01293643, "A Study to Compare the Efficacy and Safety of a Combination of Ketoconazole and Clindamycin Compared to Tetracycline/Amphotericin B Combination Cream for the Treatment of Bacterial Vaginosis and Vaginal Candidiasis (P08077)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01293643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*